12:00 AM
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Other News

Neoprobe diagnostic news

Neoprobe will appoint Peter Drake and Jess Jones to its board as part of an agreement with investor Platinum Montaur Life Sciences LLC. In return, Platinum will not engage in any independent proxy solicitation. The agreement follows several months of discussions...

Read the full 184 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >